Sadly I think access to these regulations costs because they can. They know companies will need access and that they will be willing to pay as they will see it as a cost of doing business. Is it shady? Yes. But it is something that companies have to deal with. It is one of the many things that can hamper the growth of biotech startups.

One possible solution could be a database that a company would pay for access to. Something like the way you can pay for access to a journal and get all the papers published in it. A company could pay a flat monthly or yearly fee to get access to any document regulations related to whatever the specific company is interested in. That way companies can still make money and the companies that need the information are not priced out of getting that information.